Cannabis not made safer by increasing its CBD content

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-11-18 03:45 GMT | Update On 2022-11-18 03:45 GMT

Cannabis nowadays is widely used for recreational and medicinal drugs. New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found no evidence that cannabidiol (CBD) reduces the negative effects of cannabis.

The research, published in Neuropsychopharmacology, challenges the commonly held belief that using cannabis that contains higher levels of cannabidiol protects the user from psychotic experiences and memory problems, and suggests that this should be considered by policy makers currently exploring the topic of medicinal and recreational use.

46 healthy volunteers completed a randomised and double-blind trial. Over the course of four experiments, each participant inhaled cannabis vapour containing 10mg of Delta-9-tetrahydrocannabinol and a differing level of cannabidiol (0mg, 10mg, 20mg, or 30mg). They then completed a series of tasks, questionnaires and interviews designed to measure the effect on their cognitive abilities, severity of psychotic symptoms, and how pleasurable the drug was.

In conclusion this study, explored the effect of altering the cannabidiol: Delta-9-tetrahydrocannabinol ratio in cannabis. However, they found increasing the dose of cannabidiol did not significantly change the effects of Delta-9-tetrahydrocannabinol on cognitive performance, psychotic symptoms or how pleasurable the drug experience was.

Reference:

Cannabis not made safer by increasing its CBD content; KING'S COLLEGE LONDON; JOURNAL: Neuropsychopharmacology, DOI: 10.1038/s41386-022-01478-z.

Full View

Article Source : Neuropsychopharmacology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Cannabis not made safer by increasing its CBD content

Similar News

India Sees Sharp Rise in Deaths from Lifestyle Diseases: Global Study Finds

WHO Updates Essential Medicines List, Adds Cancer, Diabetes and Obesity Drugs

Common Nasal Spray Cuts COVID Risk by Two-Thirds in Clinical Trial

Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study

Study Reveals Potassium-Rich Foods May Lower Irregular Heartbeat Risk

Study Reveals Daily Intake of Five Mushrooms May Reduce Alzheimer's and Heart Disease Risk

Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ?

The Prediabetes Show, Episode 4: Metformin in Prediabetes - A Vaccination Pill for Diabetes Prevention in 65 Countries